title: [Update on kinase inhibitors].
authors.affiliation: Abteilung Innere Medizin II, Rheumatologie, Schlosspark-Klinik, Lehrkrankenhaus der Charité - Universitätsmedizin Berlin, Heubnerweg 2, 14059, Berlin, Deutschland. rieke.alten@schlosspark-klinik.de.
authors.forename: R
authors.initials: R
authors.lastname: Alten
mesh_terms: D000818:Animals; D000893:Anti-Inflammatory Agents / Q000008:administration & dosage / Q000009:adverse effects; D000911:Antibodies, Monoclonal / Q000008:administration & dosage / Q000009:adverse effects; D018501:Antirheumatic Agents / Q000008:administration & dosage / Q000009:adverse effects; D001172:Arthritis, Rheumatoid / Q000175:diagnosis / Q000188:drug therapy* / Q000276:immunology*; D004305:Dose-Response Relationship, Drug; D016903:Drug Monitoring / Q000379:methods*; D019317:Evidence-Based Medicine; D006801:Humans; D058990:Molecular Targeted Therapy / Q000379:methods*; D047428:Protein Kinase Inhibitors / Q000008:administration & dosage* / Q000009:adverse effects / Q000276:immunology; D011494:Protein Kinases / Q000276:immunology*; D016896:Treatment Outcome
chemical_list: D000893:Anti-Inflammatory Agents; D000911:Antibodies, Monoclonal; D018501:Antirheumatic Agents; D047428:Protein Kinase Inhibitors; D011494:Protein Kinases